SLC11A1, solute carrier family 11 member 1, 6556

N. diseases: 141; N. variants: 14
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs17221959
rs17221959
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0003873
Disease:
Rheumatoid Arthritis
0.010 GeneticVariation BEFREE CONCLUSIONS This study suggested that the TT genotype and T allele in rs17221959 decreased RA risk. 31316048 2019
dbSNP: rs17221959
rs17221959
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0023290
Disease:
Leishmaniasis, Visceral
0.010 GeneticVariation BEFREE We found that rs17235409 (D543N) and rs17235416 (1729 + 55del4) are significantly associated with a risk for cutaneous leishmaniasis (CL), whereas rs17221959, rs2279015, and rs17235409 are associated with visceral leishmaniasis (VL). 31230160 2019
dbSNP: rs17221959
rs17221959
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0023283
Disease:
Leishmaniasis, Cutaneous
0.010 GeneticVariation BEFREE We found that rs17235409 (D543N) and rs17235416 (1729 + 55del4) are significantly associated with a risk for cutaneous leishmaniasis (CL), whereas rs17221959, rs2279015, and rs17235409 are associated with visceral leishmaniasis (VL). 31230160 2019
dbSNP: rs17235416
rs17235416
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0023290
Disease:
Leishmaniasis, Visceral
0.010 GeneticVariation BEFREE We found that rs17235409 (D543N) and rs17235416 (1729 + 55del4) are significantly associated with a risk for cutaneous leishmaniasis (CL), whereas rs17221959, rs2279015, and rs17235409 are associated with visceral leishmaniasis (VL). 31230160 2019
dbSNP: rs17235416
rs17235416
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0023283
Disease:
Leishmaniasis, Cutaneous
0.010 GeneticVariation BEFREE We found that rs17235409 (D543N) and rs17235416 (1729 + 55del4) are significantly associated with a risk for cutaneous leishmaniasis (CL), whereas rs17221959, rs2279015, and rs17235409 are associated with visceral leishmaniasis (VL). 31230160 2019
dbSNP: rs2279015
rs2279015
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0023283
Disease:
Leishmaniasis, Cutaneous
0.010 GeneticVariation BEFREE We found that rs17235409 (D543N) and rs17235416 (1729 + 55del4) are significantly associated with a risk for cutaneous leishmaniasis (CL), whereas rs17221959, rs2279015, and rs17235409 are associated with visceral leishmaniasis (VL). 31230160 2019
dbSNP: rs17235409
rs17235409
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0041834
Disease:
Erythema
0.010 GeneticVariation BEFREE Interactions between ITPKC rs28493229_GG and SLC11A1 rs17235409_GA and between ITPKC rs10420685_GG and SLC11A1 rs17235409_AA were strongly associated with BCG injection site erythema. 29214786 2018
dbSNP: rs17235416
rs17235416
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0030293
Disease:
Pancreatic Insufficiency
0.010 GeneticVariation BEFREE There were interaction between the rs3788766, rs7512462, rs17235416, and rs17563161 variants, and CFTR mutations with pancreatic insufficiency (PI), onset of digestive symptoms, and presence of mucoid Pseudomonas aeruginosa. 29635781 2018
dbSNP: rs17235416
rs17235416
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0267963
Disease:
Exocrine pancreatic insufficiency
0.010 GeneticVariation BEFREE There were interaction between the rs3788766, rs7512462, rs17235416, and rs17563161 variants, and CFTR mutations with pancreatic insufficiency (PI), onset of digestive symptoms, and presence of mucoid Pseudomonas aeruginosa. 29635781 2018
dbSNP: rs77624405
rs77624405
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0026691
Disease:
Mucocutaneous Lymph Node Syndrome
0.010 GeneticVariation BEFREE SNP rs77624405 in SLC11A1 was associated with KD. 29214786 2018
dbSNP: rs17235409
rs17235409
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0521158
Disease:
Recurrent tumor
0.010 GeneticVariation BEFREE Our results suggest that no significant difference was found for NRAMP1 and hGPX1 gene polymorphisms associated with recurrence time, muscle invasion frequency and disease-free survival, nevertheless, we observed that the NRAMP1 D543N GG genotype group had a shorter time to tumor recurrence. 27069153 2016
dbSNP: rs751683612
rs751683612
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0041296
Disease:
Tuberculosis
0.010 GeneticVariation BEFREE In conclusion, our data suggest that TLR4 (D299G and T399I) and TNF (-308G/A) genetic polymorphisms may influence the risk of developing tuberculosis after exposure to Mycobacterium. 26774366 2016
dbSNP: rs2276631
rs2276631
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C4543948
Disease:
Localized cutaneous leishmaniasis
0.010 GeneticVariation BEFREE Alleles rs2276631-C (P = 0.02; OR [95%CI] = 2.11 [1.16-3.86]) and rs2279015-G (P = 0.005; OR [95%CI] = 2.42 [1.33-4.41]) of SLC11A1, were associated with susceptibility to VL, whereas genotypes rs2276631 C/C (P = 0.003; OR [95%CI] = 2.65 [1.41-5.00]) and rs2279015 G/G (P = 0.018; OR [95%CI] = 2.05 [1.15-3.64]) were significantly increased in CL and VL patients, respectively. 25603101 2015
dbSNP: rs2276631
rs2276631
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0023290
Disease:
Leishmaniasis, Visceral
0.010 GeneticVariation BEFREE Alleles rs2276631-C (P = 0.02; OR [95%CI] = 2.11 [1.16-3.86]) and rs2279015-G (P = 0.005; OR [95%CI] = 2.42 [1.33-4.41]) of SLC11A1, were associated with susceptibility to VL, whereas genotypes rs2276631 C/C (P = 0.003; OR [95%CI] = 2.65 [1.41-5.00]) and rs2279015 G/G (P = 0.018; OR [95%CI] = 2.05 [1.15-3.64]) were significantly increased in CL and VL patients, respectively. 25603101 2015
dbSNP: rs2279015
rs2279015
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C4543948
Disease:
Localized cutaneous leishmaniasis
0.010 GeneticVariation BEFREE Alleles rs2276631-C (P = 0.02; OR [95%CI] = 2.11 [1.16-3.86]) and rs2279015-G (P = 0.005; OR [95%CI] = 2.42 [1.33-4.41]) of SLC11A1, were associated with susceptibility to VL, whereas genotypes rs2276631 C/C (P = 0.003; OR [95%CI] = 2.65 [1.41-5.00]) and rs2279015 G/G (P = 0.018; OR [95%CI] = 2.05 [1.15-3.64]) were significantly increased in CL and VL patients, respectively. 25603101 2015
dbSNP: rs3731865
rs3731865
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0004364
Disease:
Autoimmune Diseases
0.010 GeneticVariation BEFREE Significant associations were observed between the 469+14G/C polymorphism (rs3731865) and autoimmune disease (OR=1.30 (1.04-1.64)) and rheumatoid arthritis (OR=1.60 (1.20-2.13)) and between the -237C/T polymorphism (rs7573065) and inflammatory bowel disease (OR=0.60 (0.43-0.84)). 25856512 2015
dbSNP: rs3731865
rs3731865
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0021390
Disease:
Inflammatory Bowel Diseases
0.010 GeneticVariation BEFREE Significant associations were observed between the 469+14G/C polymorphism (rs3731865) and autoimmune disease (OR=1.30 (1.04-1.64)) and rheumatoid arthritis (OR=1.60 (1.20-2.13)) and between the -237C/T polymorphism (rs7573065) and inflammatory bowel disease (OR=0.60 (0.43-0.84)). 25856512 2015
dbSNP: rs7573065
rs7573065
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0021390
Disease:
Inflammatory Bowel Diseases
0.010 GeneticVariation BEFREE Significant associations were observed between the 469+14G/C polymorphism (rs3731865) and autoimmune disease (OR=1.30 (1.04-1.64)) and rheumatoid arthritis (OR=1.60 (1.20-2.13)) and between the -237C/T polymorphism (rs7573065) and inflammatory bowel disease (OR=0.60 (0.43-0.84)). 25856512 2015
dbSNP: rs7573065
rs7573065
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0004364
Disease:
Autoimmune Diseases
0.010 GeneticVariation BEFREE Significant associations were observed between the 469+14G/C polymorphism (rs3731865) and autoimmune disease (OR=1.30 (1.04-1.64)) and rheumatoid arthritis (OR=1.60 (1.20-2.13)) and between the -237C/T polymorphism (rs7573065) and inflammatory bowel disease (OR=0.60 (0.43-0.84)). 25856512 2015
dbSNP: rs7573065
rs7573065
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0003873
Disease:
Rheumatoid Arthritis
0.010 GeneticVariation BEFREE Significant associations were observed between the 469+14G/C polymorphism (rs3731865) and autoimmune disease (OR=1.30 (1.04-1.64)) and rheumatoid arthritis (OR=1.60 (1.20-2.13)) and between the -237C/T polymorphism (rs7573065) and inflammatory bowel disease (OR=0.60 (0.43-0.84)). 25856512 2015
dbSNP: rs17235409
rs17235409
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C1619738
Disease:
Immune Reconstitution Inflammatory Syndrome
0.010 GeneticVariation BEFREE Susceptibility to TB-IRD associated with carriage of TNFA-1031*T (rs1799964; P=0.05) and SLC11A1 D543N*G (rs17235409; P=0.04) in Cambodian patients and carriage of IL18-607*G (rs1946518; P=0.02) and VDR FokI (F/f)*T (rs10735810; P=0.05) in Indian patients. 23594560 2013
dbSNP: rs17235409
rs17235409
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C1096197
Disease:
Immune reconstitution syndrome
0.010 GeneticVariation BEFREE Susceptibility to TB-IRD associated with carriage of TNFA-1031*T (rs1799964; P=0.05) and SLC11A1 D543N*G (rs17235409; P=0.04) in Cambodian patients and carriage of IL18-607*G (rs1946518; P=0.02) and VDR FokI (F/f)*T (rs10735810; P=0.05) in Indian patients. 23594560 2013
dbSNP: rs2276631
rs2276631
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0030524
Disease:
Paratuberculosis
0.010 GeneticVariation BEFREE Only rs2276631 SNP was associated with MS. MAP DNA was detected in 23 out of 100 MS patients (23%) and in 7 out of 100 HCs (7%). 23492997 2013
dbSNP: rs17235409
rs17235409
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0026918
Disease:
Mycobacterium Infections
0.010 GeneticVariation BEFREE Collectively, our results suggest an association of NRAMP1 3'-UTR and D543N polymorphisms with susceptibility to mycobacterial infection in Tunisian populations in relation to age and sex. 22609013 2012
dbSNP: rs17235409
rs17235409
Entrez Id: 6556
Gene Symbol: SLC11A1
SLC11A1
CUI: C0036202
Disease:
Sarcoidosis
0.010 GeneticVariation BEFREE We investigated the association between SA and four polymorphisms of the SLC11A1 gene, including a single nucleotide change in intron 4 (INT4); a nonconservative single-base substitution at codon 543 (D543N); a TGTG deletion in the 3' untranslated region; and the functional (GT)(n) repeat polymorphism in the 5' region, in 95 Turkish SA patients and 150 healthy controls, by using amplification refractory mutation system-polymerase chain reaction and sequencing. 22160516 2012